The regulator is seeking further 'corrective actions' from the manufacturers, who each issued voluntary product recalls over Cronobacter sakazakii fears in the past 12 months.
A recent warning letter issued by the Food and Drug Administration makes clear the danger marketers run into when using the words “inflammation” and “chronic” in the same breath, even in connection with an unusual product for that sort of claim, such...